In order to access this content you must be logged in and have a subscription to PL Intelligence.

PL Intelligence is a one-stop environment for time-conscious executives. Keeping you abreast of the latest developments in the life sciences industry, saving you time and money when you need it most.
Immune Response to pursue development of preventive HIV vaccine
Coley and SmithKline Beecham sign collaboration
ImmunoVaccine Technologies Broadens Its Patent Protection to Japan
Immune Response receives two U.S. patents
Immune Response Corporation not to proceed with HIV study
Positive clinical results for Powderject DNA vaccine
Immune Response announces restructuring of license agreement
Coley to collaborate with Ludwig Institute for Cancer Research
The Immune Response Corporation announces payment from Agouron Pharmaceuticals